Gharda CEO Ram Seethapathi outlines how generics reshaped chlorpyrifos — from pricing power to global access — and what it ...
I t is a rare thing to see Josh Shapiro sweat. For all the grief the Pennsylvania governor gets for imitating Barack ...
Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar ...
On October 3, 2025, the U.S. Food and Drug Administration (FDA) announced a prioritization pilot program for reviewing abbreviated new drug applications (ANDAs). ANDAs are submissions for generic ...
If you’re going to be a hacker, learning C is a rite of passage. If you don’t have much experience with C, or if your experience is out of date, you very well may benefit from hearing [Nic Barker] ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United ...
The U.S. Food and Drug Administration has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United States, the regulator ...
The FDA is launching a new pilot prioritization program for the review of abbreviated new drug applications that would provide faster reviews for generic companies that test and manufacture their ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. The Food and Drug Administration seal is seen at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback